Sensei Biotherapeutics In...

NASDAQ: SNSE · Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT

Sensei Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.16M -34.1M -48.59M -36.79M
Depreciation & Amortization
1.32M 1.35M 1.35M 685K
Stock-Based Compensation
3.13M 4.45M 5.81M 5.66M
Other Working Capital
-44K -2M -1.01M 1.54M
Other Non-Cash Items
1.52M 603K 1.4M 57K
Deferred Income Tax
n/a n/a n/a 19K
Change in Working Capital
-489K -4.33M 1.01M 117K
Operating Cash Flow
-24.67M -32.02M -39.03M -30.26M
Capital Expenditures
-146K -180K -321K -2.03M
Cash Acquisitions
n/a n/a 15K 318K
Purchase of Investments
-44.59M -21.15M -46.87M -183.67M
Sales Maturities Of Investments
67.18M 59.58M 97.12M 42.26M
Other Investing Acitivies
n/a 166K 50.27K -141.09K
Investing Cash Flow
22.44M 38.41M 49.95M -143.12M
Debt Repayment
-811K -761K -629K -255K
Common Stock Repurchased
n/a -10.38M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -76K n/a 109K
Financial Cash Flow
-787K -11.17M -287K 163.94K
Net Cash Flow
-3.02M -4.78M 10.64M -9.44M
Free Cash Flow
-24.82M -32.2M -39.35M -32.28M